Evogene to Receive $3.5 million Payment Related to Patent Portfolio under its Existing Seed Traits Collaboration with Bayer
REHOVOT, Israel, Dec. 8, 2022 /PRNewswire/ — Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) (the “Company”, “Evogene”), a leading computational biology company targeting to revolutionize life-science prod…